Professional Development Committee
We're growing!
Following a vote at the 2025 Annual General Meeting, the structure and composition of our governing committees and groups are changing.
We'll soon be recruiting new people into various leadership positions - check back soon for more information.
Sandrine Willaime-Morawek
Dr. Sandrine Willaime-Morawek is an Associate Professor in Stem Cells and Neurobiology and a Principal Investigator at the University of Southampton.
Tara Spires-Jones
Professor Tara Spires-Jones, DPhil(Oxon), FMedSci is Director of the Centre for Discovery Brain Sciences at the University of Edinburgh. Her research focuses on mechanisms of synapse degeneration in Alzheimer’s disease. She discovered that soluble forms of the pathological proteins amyloid beta and tau contribute to synapse degeneration. Further, her group demonstrated that pathological forms of tau spread through the brain via synaptic connections.
In addition to research, Prof Spires-Jones is passionate about communicating scientific findings to the public; increasing the rigour and reproducibility in translational neuroscience; promoting inclusivity and diversity in science; and supporting career development of neuroscientists.
Talitha Kerrigan
Dr. Talitha Kerrigan is a Research Fellow at the University of Exeter.
Dr. Kerrigan is dedicated to advancing the understanding of neurodegenerative diseases, contributing to potential therapeutic strategies for Alzheimer's.
Talitha's research focuses on the dynamic role of astrocyte-secreted apolipoprotein E4 in Alzheimer's disease, using induced pluripotent stem cells from donor patients. She is also investigating the role of microglia in Alzheimer's disease, particularly the mechanisms of amyloid beta clearance.
Bethany Facer
Bethany Facer is a PhD student at the University of Liverpool.
Bethany's research focuses on neuroimaging in disease populations, he current project investigates imaging alterations in herpes simplex virus encephalitis and their associations with inflammatory markers. She is also a member of the neuroimaging working group for the COVID Clinical Neuroscience Study (COVID-CNS), analyzing data on SARS-CoV-2 induced movement disorders.
Beyond the lab, Bethany is an enthusiastic science communicator, leading the BNA2025 Public programme and reaching the UK final of FameLab in 2024.
Charlotte Shepherd
Tatiana Rosenstock
Dr Tatiana Rosenstock is a senior neuroscience leader with over 20 years of experience in molecular, cellular, and behavioural neuroscience. She holds a Master and PhD in Pharmacology, post-doctoral training in Neuroscience in Portugal and at MIT (USA), and an MBA Essentials from the London School of Economics.
Her expertise spans neuropsychiatric and neurodegenerative disorders—including Schizophrenia, Huntington’s disease, ALS, Alzheimer’s, and Parkinson’s—with research focused on metabolism, biomarkers, epigenetics, microglial biology, and mitochondrial and autophagy dysfunction.
Tatiana has authored more than 40 scientific publications and presented at over 120 international meetings. She has led multidisciplinary research groups, supervised over 20 students, and held key academic roles in ethics, biosecurity, and postgraduate training. She has also managed diverse R&D portfolios and provided scientific support to academic and industry stakeholders. She is also a recipient of awards from the Newton Fund, Ernest Rutherford Fellowship, and NIH.
Ryan Stanyard
Volko Straub